Leeds tech roundup, week of 28 September

Funding & deals

• Avacta has launched a fresh cash raise following positive clinical data for its cancer drug programme. BusinessDesk reports that the Wetherby-based company is seeing promising results in patient trials, which serves as a critical indicator for its ongoing development pipeline. This move comes as the firm looks to maintain momentum in its oncology research efforts. (BusinessDesk)

• Surgical Innovations reported a decline in profits, citing the impact of US tariffs on its operations. According to BusinessDesk, the company is managing the fallout from these trade barriers, which have created a challenging environment for its medical device exports. This serves as a reminder of how global trade policy directly affects Leeds-based manufacturing and health-tech firms. (BusinessDesk)

Hiring & teams

• Vivify has appointed a new product expert to its team, bringing in experience from JustGiving. BusinessCloud reports that the EdTech 50 firm is focusing on strengthening its leadership as it scales its platform for school facility bookings. This hire suggests a strategic push to refine the user experience as the company grows its footprint. (BusinessCloud)

Product & launches

• Cizzle Biotech received accreditation for its lung cancer blood test for clinical use in the United States. The Yorkshire Post reports that this is a significant milestone for the firm, potentially opening up a major market for its diagnostic technology. This regulatory progress marks a shift from research and development into active clinical application. (Yorkshire Post)

• Leeds agency activity remains steady with a new campaign launch for a savings platform. According to Insider Media Ltd, the creative work highlights the ongoing demand for digital marketing services among financial technology companies in the region. This project underscores the continued role of Leeds-based agencies in shaping the brand identity of national fintech players. (Insider Media Ltd)